Clinical trial
A Local Register Study For Major Depression Of Paroxetine Controlled Release
NCT00368303 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00368303 |
|---|---|
| Title | A Local Register Study For Major Depression Of Paroxetine Controlled Release |
| Official title | A Multicentre, Double-blind, Active Controlled Trial to Evaluate the Clinical Effects of Immediate Release Paroxetine and Controlled Release Paroxetine in the Treatment of Major Depression |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Depressive Disorder, Major, Major Depressive Disorder (MDD) |
| Intervention type | Drug |
| Interventions | Paroxetine CR, Paroxetine IR |
| Enrollment | 362 |
| Start date | Dec 1, 2006 |
| First posted | Aug 24, 2006 |
| Last update posted | Jun 4, 2012 |
| Countries | China |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: